{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:01:02Z","timestamp":1788433262063,"version":"build-2803163510"},"reference-count":73,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T00:00:00Z","timestamp":1289433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Depending on definitions and patient characteristics, 5\u201340% of patients with lymphoid malignancies are hard\u2010to\u2010mobilize. Several premobilization factors such as previous chemotherapy (CT), disease, marrow infiltration and platelet count at the time of mobilization influence the efficacy of CD34<jats:sup>+<\/jats:sup> cell mobilization. In general, however, prediction of hard\u2010to\u2010mobilize patient is difficult. Postmobilization factors especially low blood CD34<jats:sup>+<\/jats:sup> counts are important in clinical practice as we have now ways to enhance mobilization at this point. Plerixafor combined with granulocyte\u2010colony stimulating factor (G\u2010CSF) has significantly increased efficacy of remobilization in patients who have failed a previous mobilization attempt with a success rate of about 70%. Addition of plerixafor to G\u2010CSF or more recently to a mobilization regimen consisting of CT\u2003+\u2003G\u2010CSF is promising as blood CD34<jats:sup>+<\/jats:sup> counts can be increased \u2003three to fivefold to facilitate effective collection with less aphaeresis sessions. As plerixafor is expensive, development of practical algorithms for its use is important to make blood stem cell mobilization and collection more efficient in a cost\u2010effective way. This review attempts to summarize current treatment strategies in hard\u2010to\u2010mobilize patients with lymphoid malignancies.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2010.01520.x","type":"journal-article","created":{"date-parts":[[2010,8,29]],"date-time":"2010-08-29T19:11:39Z","timestamp":1283109099000},"page":"463-471","source":"Crossref","is-referenced-by-count":41,"title":["Mobilization strategies in hard\u2010to\u2010mobilize patients with lymphoid malignancies"],"prefix":"10.1111","volume":"85","author":[{"given":"Esa","family":"Jantunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Kvalheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,11]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.69"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.410"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.07.004"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.11.012"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0468"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705908"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.7209"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174946"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.02.002"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000095872"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21314"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703575"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.6.1360"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2004.13.598"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.9.3148"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.1999.11746443"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.127"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04837.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04951.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705298"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705763"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70021-8"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01448.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403341"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.04.013"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04107.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21400"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704466"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705360"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0812-9"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00960.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009057639"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200061"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428191003624231"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404801"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.02.011"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.118"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.141"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1449"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705897"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802641979"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2743091.x"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701461"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704184"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190400002251"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.01026.x"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.54"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.236"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.08.011"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.119"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.93"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.128"},{"key":"e_1_2_8_54_2","first-page":"24","article-title":"The use of plerixafor for blood stem cell mobilisation reduces the frequency of mobilisation failure in patients planned to undergo autologous transplantation","volume":"4","author":"Josefsen D","year":"2010","journal-title":"Eur Hematol"},{"issue":"2","key":"e_1_2_8_55_2","first-page":"S258","article-title":"Successful peripheral blood stem cell harvest in mobilization\u2010refractory lymphoma patients","volume":"45","author":"Segel E","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"e_1_2_8_56_2","first-page":"S323","article-title":"Predictability of stem cell mobilization following G\u2010CSF plus\/minus plerixafor based on d+4 peripheral blood CD34+ cell levels: basis for a pre\u2010emptive model of plerixafor use in patients with lymphoma and myeloma who mobilized poorly","volume":"45","author":"Duarte RF","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1554"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0440"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.249"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1080\/14653240902849770"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2006.0087"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.3109\/14653240903121245"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-186668"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.142"},{"issue":"2","key":"e_1_2_8_65_2","first-page":"O152","article-title":"Cyclophosphamide or plerixafor and G\u2010CSF for stem cell mobilization: initial cost comparison analysis","volume":"45","author":"Jagasia M","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.06.010"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1534"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.04.004"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.10.2547"},{"key":"e_1_2_8_70_2","first-page":"937","article-title":"Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma","volume":"17","author":"Demirer T","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_71_2","first-page":"846","article-title":"Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma","volume":"87","author":"Boccadoro M","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704455"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1080\/14653240701508429"},{"key":"e_1_2_8_74_2","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V85.9.2619.bloodjournal8592619","article-title":"Peripheral blood progenitor cell (PBPC) counts during steady\u2010state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R\u2010metHuG\u2010CSF) \u2013supported cytotoxic chemotherapy","volume":"85","author":"Fruehauf S","year":"1995","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2010.01520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2010.01520.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:39:12Z","timestamp":1698655152000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2010.01520.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,11]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1600-0609.2010.01520.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01520.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,11]]}}}